ORIGINAL INVESTIGATION. Follow-up of a Randomized Trial in Older Women With Osteopenia

Size: px
Start display at page:

Download "ORIGINAL INVESTIGATION. Follow-up of a Randomized Trial in Older Women With Osteopenia"

Transcription

1 ORIGINAL INVESTIGATION Long-term Outcomes of Exercise Follow-up of a Randomized Trial in Older Women With Osteopenia Raija Korpelainen, PhD; Sirkka Keinänen-Kiukaanniemi, MD, PhD; Pentti Nieminen, PhD; Jorma Heikkinen, MD, PhD; Kalervo Väänänen, MD, PhD; Juha Korpelainen, MD, PhD Background: Long-term evidence from randomized trials of the effectiveness of exercise in preventing disability and fall-related fractures in elderly people has been lacking. Methods: We performed extended follow-up of 160 women (aged years at baseline) with osteopenia in a population-based, randomized, controlled exercise trial. The trial was conducted from April 1 through April 30, Follow-up was conducted from May 1, 2001, through December 31, Mean total time in observation was 7.1 years. Primary outcome measures were femoral neck bone mineral density, postural sway, and leg strength. Secondary outcome measures were hospitaltreated fractures and functional ability measures. Outcomes were measured annually using masked assessors. Results: There was a significant difference between groups in favor of exercise in terms of postural sway (group time interaction, P =.005), walking speed (group time interaction, P.001), and Frenchay Activities Index score (group x time interaction, P=.001). The bone mineral density decreased similarly across time in both groups. The incidence rate of fractures during the total follow-up among women in the exercise group vs women in the control group was 0.05 vs 0.08 per 1000 person-years (Poisson incidence rate ratio, 0.68; 95% confidence interval, ). There were no hip fractures in the exercise group, whereas 5 hip fractures occurred in the control group. One woman in the exercise group and 8 women in the control group died (Poisson incidence rate ratio, 0.11; 95% confidence interval, ). Conclusion: Mainly home-based exercises followed by voluntary home training seem to have a long-term effect on balance and gait and may even protect high-risk elderly women from hip fractures. Trial Registration: clinicaltrials.gov Identifier: NCT Arch Intern Med. 2010;170(17): Author Affiliations: Department of Sports and Exercise Medicine (Dr R. Korpelainen) and Clinic of Osteoporosis (Dr Heikkinen), Oulu Deaconess Institute; Department of Medical Technology, Institute of Biomedicine (Dr R. Korpelainen); Faculty of Medicine (Dr Nieminen); Department of Neurology (Drs R. Korpelainen and J. Korpelainen); and Unit of General Practice, Institute of Health Sciences, University Hospital of Oulu (Drs R. Korpelainen and Keinänen-Kiukaanniemi), University of Oulo, Oulo, Finland; and Institute of Biomedicine, University of Turku, Turku, Finland (Dr Väänänen). FALL-RELATED FRACTURES ARE associated with long-term pain, functional impairment, and increased risks of institutionalization and death in elderly women. Hip fractures place the greatest demands on resources and have the greatest effect on patients because they are associated with high mortality rates and increased morbidity. 1-4 Falls are responsible for at least 90% of all hip fractures. 5 Recent meta-analyses concluded that exercise is successful in reducing fall risk and preventing falls in elderly people. 6-8 Evidence from prospective cohort studies indicates that a more active lifestyle is associated with a reduced risk of fractures in elderly women and that the risk goes down as physical activity level goes up Several randomized controlled trials also have shown the effect of exercise on surrogate end points of efficacy, such as bone mineral density (BMD), balance, and lower extremity strength Individuals with osteoporosis are at increased risk for fractures, not only because of low BMD but also owing to their decreased balance and muscle strength. 19 Although there is evidence of the effectiveness of exercise in the prevention of falls in healthy populations, the effectiveness of exercise in elderly women with osteoporosis has been less studied. To our knowledge, a randomized controlled exercise trial with fractures as an outcome measure has never been performed. This is largely a result of methodological challenges such as study sample sizes, participants who drop out of a study, compliance, and masking. However, there is an urgent need to develop effective public health strategies for prevent- 1548

2 1689 Patients were assessed for eligibility (1997) 1529 Patients were excluded 696 Had distal radius BMD 2 SDs 270 Had hip BMD 2 SDs 463 Refused to participate 96 Medical reasons 4 Could not be contacted 160 Women with hip and radius osteopenia were randomized Postintervention Measurement ( ) Exercise Intervention ( ) 84 Were allocated to exercise group 69 (82%) Were available for the last trial visit 55 (66%) Were available for the final follow-up visit (2004) 15 Did not complete the trial 9 Withdrew consent 6 Were excluded owing to medical reasons 14 Did not complete the extended follow-up 1 Died of cancer 13 Withdrew 6 Medical reasons 7 Unknown reason Fracture data and causes of death in all original 1689 women were obtained until December 31, Were allocated to control group 67 (88%) Were available for the last trial visit 45 (59%) Were available for the final follow-up visit (2004) 9 Did not complete the trial 3 Withdrew consent 6 Were excluded owing to medical reasons 22 Did not complete the extended follow-up 8 Died 5 CVD 2 Cancer 1 Bicycle accident 1 Hospitalization 13 Withdrew 7 Medical reasons 6 Unknown reason Figure. Study flowchart. BMD indicates bone mineral density; CVD, cardiovascular disease. ing fractures. Of all the methods of fracture prevention, regular physical activity is the only one that provides other considerable health-related benefits that may have a positive, albeit indirect, effect on fall and fracture risk in older adults. Previously, we conducted a 30-month, populationbased, randomized, controlled exercise trial aimed at reducing the risk factors for fractures in elderly women with osteopenia. 13,14 The aim of the present extended, 7-year follow-up of that trial was to assess the long-term effect of the chosen exercise regimen on balance, strength, and functional performance and its effect on the risk of fractures in elderly women. On the basis of the results of the original trial, we hypothesized that the women in the exercise group would maintain their higher performance level compared with the control group and that they would have fewer fractures. METHODS The study flowchart is presented in the Figure. The original exercise trial was conducted between October 1, 1998, and March 31, The follow-up visits were performed annually at 4 years, 5 years, and 6 years from the beginning of the trial. The last follow-up measurements were performed in spring Data on fractures and causes of death were obtained from the baseline measurement in 1998 until December 31, The study design, recruitment process, and trial procedures have been described in detail previously. 13,14,20 The follow-up protocol was approved by the local ethics committee. All participants gave written informed consent at the beginning of the study and again in 2001 for the extended follow-up period. PARTICIPANTS Originally, we used the Finnish Population Register Centre to identify all women living in Oulu in 1997 and born between 1924 and 1927 (n=1689) (Figure). The women were sent a questionnaire about their lifetime medical and lifestyle factors. 20 The women were screened for weight, height, and distal radius and hip BMD. Women who had a femoral neck (n=270) and distal radius (n=696) BMD value of at least 2 SDs lower than the reference value were excluded. Other exclusion criteria were healthor medication-related factors (acute illness or unstable chronic illness, malignant neoplasm, continuous use of oral corticosteroids, use of hormone therapy, and use of osteoporosis medication; n=84), use of walking aid devices other than a stick (n=4), severe cognitive impairment (n=4), bilateral hip joint replacement (n=1), and involvement in other interventions (n=3). Women who had a femoral neck and distal radius BMD value less than 2 SDs lower than the reference value and who 1549

3 Table 1. Characteristics of 160 Study Participants at Baseline and at the Final Visit Baseline 6-y Final Visit Characteristic EG (n=84) CG (n=76) EG (n=55) CG (n=45) Age, mean (SD), y 72.7 (1.1) 72.6 (1.2) 78.6 (1.1) 78.4 (1.1).08 a Height, mean (SD), cm (4.9) (5.4) (5.2) (4.6).18 a Weight, mean (SD), kg 61.2 (7.9) 62.2 (9.2) 60.0 (9.1) 61.9 (10.9).48 a BMI, mean (SD) 25.7 (3.4) 25.5 (3.5) 25.9 (3.9) 25.9 (4.3).65 a Body fat, mean (SD), % 40.7 (4.2) 39.4 (5.9) 45.0 (4.2) 44.4 (4.6).93 a Medication use, No. (%) Estrogen 3 (3.6) 1 (1.3) 0 0 Other medication for osteoporosis (25.5) 9 (20.0).51 b Oral corticosteroids (1.8) 1 (2.2).91 b Thiazide diuretics 9 (10.7) 11 (14.5) 6 (10.9) 5 (11.1).97 b Statins 4 (4.8) 6 (7.9) 7 (12.7) 7 (15.6).67 b Thyroid hormone 8 (9.5) 4 (5.3) 4 (7.3) 5 (11.1).51 b Lifestyle and nutritional factors Daily smoking, No. (%) 5 (6.0) 8 (10.5) 6 (10.9) 6 (13.3).86 b Weekly consumption of alcohol, No. (%) 4 (4.8) 6 (7.9) 2 (3.6) 3 (6.7).57 b Calcium intake, mean (SD), mg/d 846 (387) 773 (299) 919 (414) 814 (418).37 a No regular physical exercise, No. (%) 7 (8.3) 8 (10.5) 12 (21.8) 12 (26.7).63 b Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CG, control group; EG, exercise group. a P value for the difference between groups in change from baseline to the 6-year final visit, determined using independent-sample t test or 2 test. b P value for the difference between groups at the final visit, determined using 2 test. P Value fulfilled the inclusion criteria (n=160) were included in the trial in August The women were randomly assigned to an exercise group (n=84) and a control group (n=76) using computer-generated random numbers. Each participant received sequentially, according to the original identification numbers, the next random assignment in the computer list. Randomization was performed after recruitment, and it was conducted by a technical assistant not involved in the trial. EXERCISE INTERVENTION A detailed description of the intervention has been previously published. 14 In brief, the women in the exercise group were asked to attend supervised balance, leg strength, and impact training sessions once a week for a 6-month period from October through March each year. In addition, the participants were asked to train 20 minutes daily at home following a program that consisted of similar patterns of exercise to those in the supervised sessions. From April through September, the exercises took place only at home. The participants in the control group were given general health information at baseline and were asked to continue their daily routine activities. POSTINTERVENTION FOLLOW-UP All women who had participated in the intervention phase of the study were enrolled in the postintervention follow-up phase, as well as those who had withdrawn earlier (15 in the intervention group and 9 in the control group). During the followup, all study participants had a yearly visit with the same physiotherapist and nurse who had performed the measurements during the trial. The same questionnaire that had been sent to the women before the first screening visit was administered by a nurse at each visit. Fracture data were obtained for all 160 women who were enrolled in the original trial. Data on 7-year incidence of hospital-treated fragility fractures were collected from the national hospital discharge register. The Finnish register is the oldest nationwide discharge register in the world, and its coverage has been shown to be accurate, particularly for severe injuries such as bone fractures. 21 To avoid the bias of recording multiple hospitalizations for the same fracture, a comprehensive screening of patients medical records was performed manually in For patients with multiple hospitalizations due to the same fracture, only the first hospitalization was analyzed to avoid overcounting of events. If more than 1 fracture occurred at the same time, these were recorded as separate fractures. Fractures occurring in connection with motor vehicle crashes and bicycle accidents were not included. Information on the date and cause of death was obtained from the Cause of Death Register located at Statistics Finland (Helsinki) by using the underlying and immediate causes of death. MEASUREMENTS Outcome measures were assessed annually. A detailed description of the measurement protocol has been published previously. 13,14 The visits included the same procedures as during the intervention period and were similar for all participants irrespective of their former randomization group. The assessors in direct contact with participants during the study did not know to which group they had been assigned. MUSCLE STRENGTH, BALANCE, GAIT, AND FUNCTIONAL ABILITY A clinical examination was performed by the same experienced nurse at baseline and at 12 months, 24 months, 30 months, 4 years, 5 years, and 6 years from the beginning of the study. The same questionnaire that had been sent to the women before the first screening visit was administered by a nurse at each visit. 20 To evaluate the activities of daily living, the self-report version of the Frenchay Activities Index 22 (FAI) was used. Symptoms of depression were ascertained with the Geriatric Depression Scale (GDS), 23 and cognitive function was assessed with the Mini-Mental State Examination. 24 At each visit the following measurements were obtained: body weight and height, body mass index (BMI; calculated as weight in kilograms divided by height in meters squared), percentages of fat and lean mass (Body- 1550

4 stat 1500; Bodystat Ltd, Douglas, Isle of Man), Timed Up and Go (TUG) test score, 25 walking speed, 26 walking endurance, 27 and physical activity level. 13 Postural sway measurements were performed in standardized conditions using an inclinometrybased method. 13 Maximum isometric leg extensor strength was assessed bilaterally with a computerized strain gauge dynamometer (Newtest Ltd, Oulu), and grip strength was measured with a hand dynamometer (Newtest Ltd). BONE MEASUREMENTS Areal BMD and bone mineral content (BMC) measurements were performed annually at the left proximal femur using dual energy x-ray absorptiometry (DEXA; GE Lunar Corp, Madison, Wisconsin). The BMD of the dominant distal radius was measured at baseline, at 30 months, and at 6 years using peripheral dual energy x-ray absorptiometry (Osteometer DTX-200; Osteometer MediTech, Roedovre, Denmark). Assessment of calcaneal broadband ultrasound attenuation (decibels per megahertz) and speed of sound (meters per second) was performed at baseline, at 30 months, and at 6 years using quantitative ultrasound (Sahara Clinical Bone Sonometer; Hologic, Bedford, Massachusetts). The calibration and measurement, as well as quality control procedures, have been described in detail previously. 13 STATISTICAL ANALYSIS All the analyses were performed using SPSS for Windows, version 15.0 (SPSS Inc, Chicago, Illinois), and StatsDirect, version (StatsDirect Ltd, Altrincham, England), statistical software. The trial data were analyzed on an intention-to-treat basis. Originally, we estimated that at a 5% significance level we would require 64 women in each group to give 80% power to detect a 0.02-g/cm 2 difference in femoral BMD (with an SD of 0.04 g/cm 2 ) between groups. The study also had 80% power at the 5% significance level to show a difference of 2.0 cm (15.0 cm vs 13.0 cm; SD, 3.5) in postural sway at 30 months between groups. The primary outcome measures for the extended follow-up were femoral neck BMD, postural sway, and leg strength. The secondary outcome measures were hospital-treated fractures and functional ability measures (walking speed, walking endurance, and TUG test; FAI, GDS, and Mini-Mental State Examination scores). Thus, the original trial was not powered for detecting a difference in antifracture efficacy between groups. The fracture incidence rate was calculated as the number of fractures during the total amount of person-years in each group. Person-years was calculated as the time that the women were undergoing observation in the study. Fractures distal to the elbow and knee were considered as distal fractures, and fractures proximal to the elbow and knee were considered as proximal fractures. Poisson regression analysis was used to analyze the fracture and mortality rate data. Poisson incidence rate, incidence rate ratio (IRR), and P values for the incidence rate difference between groups are presented. We performed multivariate stepwise logistic regression analysis using all variables associated with any fracture in univariate analyses to evaluate the determinants of having 1 or more fractures in the pooled groups. Odds ratios with 95% confidence intervals (CIs) are presented. All the BMD and performance variables were normally distributed. The absolute and percentage changes from baseline were calculated for each characteristic. The means with 95% CIs were calculated for change within a group and for difference between groups. The independent-sample t test was used to compare the exercisers with the control group. For the dichotomous variables, the 2 test was used to evaluate the significance of the differences. The changes in bone and performance variables during the trial and posttrial follow-up period were examined using multiple linear regression analyses with generalized estimating equations (GEEs) to account for correlations among 7 repeated measurements. The GEE method extends standard regression analysis, taking into account the baseline value and correlation between repeated measurements. This method can handle cases with missing data without the need for imputation, 28 and data for a person at a certain time during follow-up are included regardless of whether data for that person are missing at other times. Also, GEE analysis takes into account the status or changing value of covariates at each visit. The bone analyses were adjusted for BMI change from baseline, calcium intake, and osteoporosis medication use. The performance models were adjusted for BMI change. RESULTS Baseline data on the exercise and control groups are given in Table 1. Sixty-nine women (82.1%) in the exercise group and 67 (88.2%) in the control group completed the trial. Fifty-five women (65.5%) in the exercise group were available for the final follow-up measurements and 45 (59.2%) in the control group. Of the 160 women, 74 (46.2%) had complete data at all 7 time points during the trial and extended follow-up. Twenty-six women (16.2%) had missing data, and 60 (37.5%) were lost to follow-up either during the trial or after the intervention. The reasons for withdrawal during the trial were unwillingness to continue (n=12), new or worsening health problems (n=7), and medication included in the initial exclusion criteria (n=5). The reasons for not completing the extended follow-up were death (n=9), health problems or family reasons (n=13), and unknown reasons (n=13). Participants who dropped out of the study were similar to those who continued to participate with respect to baseline characteristics. The changes in BMD and BMC, postural balance, strength, and functional capacity, as well as the frequency of falls and fall-related fractures during the trial, were reported previously. 13,14 The mean (SD) total time in observation was 7.1 (0.2) years in the exercise group and 6.9 (0.7) years in the control group. There were 17 hospital-treated fractures during follow-up in the exercise group, whereas 23 fractures occurred in the control group. The incidence rate of fractures during the total follow-up among the exercisers vs women in the control group was 0.05 vs 0.08 per 1000 person-years (IRR, 0.68; 95% CI, ; P=.22). When the fracture model was adjusted for changes in FAI score, gait speed, and postural sway from baseline to the final visit, gait speed was the only independent predictor of fracture incidence rate (IRR, 0.13; 95% CI, ; P=.02). There were no hip fractures in the exercise group, whereas 5 hip fractures occurred in the control group (incidence rate difference, P=.02). Distribution of fractures according to anatomical location is indicated in Table 2. Fractures were proximal in 52.2% of the control group and 17.6% of the exercise group (P=.02). Moderate lifelong physical activity decreased the overall risk of having any fracture during the total follow-up period (odds ratio, 0.22; 95% CI, ). 1551

5 Table 2. Distribution of Fractures According to Anatomical Location Within the Exercise and Control Groups a Location of Fracture Exercise Group (n=84) Control Group (n=76) Foot 2 (11.8) NA Knee/tibia/fibula 3 (17.6) 5 (21.7) Proximal femur Pertrochanteric NA 1 (4.3) Subtrochanteric NA 1 (4.3) Femoral neck NA 3 (13.0) Vertebra 1 (5.9) 1 (4.3) Clavicle 1 (5.9) NA Rib NA 1 (4.3) Humerus Proximal 1 (5.9) 4 (17.4) Distal NA 1 (4.3) Distal radius 7 (41.2) 4 (17.4) Elbow NA 1 (4.3) Hand/finger 2 (11.8) 1 (4.3) Total 17 (100.1) 23 (99.6) Abbreviation: NA, not applicable. a Data are presented as number (percentage). Percentages may not total 100 due to rounding. By the end of 2005, 1 woman (1.2%) in the exercise group had died, whereas 8 women (10.5%) in the control group had died, giving a crude death rate of per 1000 person-years in the exercise group and 0.03 per 1000 person-years in the control group (Poisson IRR, 0.11; 95% CI, ; P=.01). The woman in the exercise group died of lung cancer, whereas the main acute or underlying causes of death in the control group were cancer (n=2), cardiovascular disease (n=5), and an external cause (bicycle accident; n=1). The absolute values on the physical performance tests and the significance of the difference between groups in change across time appear in Table 3. Postural sway increased in both groups from baseline to 6 years, with the increment being more pronounced in the control group (group time interaction, P=.005). When only the 3 last postintervention measurements were included in the analyses, the difference in change between groups was of borderline significance (P=.06). The exercise group demonstrated a significant gain compared with the control group in mean leg strength during the trial. The difference between groups diminished until the 4-year follow-up visit (P=.41 for the change from baseline). During the postintervention follow-up, the exercise group had a more pronounced decrease in mean maximal leg strength than the control group (group time interaction, P=.04). The exercisers maintained their gait speed at the baseline level, whereas the women in the control group had a decrease in gait speed during the total 6-year follow-up (group time interaction, P=.001). The difference between groups was also seen during postintervention follow-up (group time interaction, P=.03). There was a significant difference in change from baseline in the 2-minute walking test score between exercisers and the control group (3.3 m vs 16.4 m; P=.06; group time interaction, P=.005). The exercisers improved their performance until the 4-year visit. In both groups, most of the decrease in walking performance occurred between years 5 and 6. The difference between groups diminished after the trial and was of borderline significance during the extended follow-up (P =.06). The difference between groups in TUG test score was practically the same at baseline and at the final visit. Group time interaction was significant during total follow-up (P.001) and postintervention follow-up (P=.04), mainly owing to improvement of the exercisers during the intervention. In the trial, activities of daily living assessed with the FAI showed a significant and similar decrease within the exercise and control groups, but during the total 6-year follow-up there was a group time interaction in favor of the exercise group (group time interaction, P.001). During the postintervention follow-up, the women in the exercise group slightly increased their score compared with the control group (group time interaction, P=.006). There was no clinically significant difference in change in GDS or Mini-Mental State Examination scores between groups across time. Table 4 gives the absolute BMD and BMC values measured with dual energy x-ray absorptiometry in the beginning of the trial and during the postintervention follow-up period, as well as the significance of the difference between groups in multiple linear regression analyses with GEEs. The BMD and BMC decreased across time, and the time trends were similar in both groups. COMMENT This population-based postintervention follow-up study showed for the first time to our knowledge that supervised, mainly home-based weight-bearing exercise was successful in reducing important risk factors for falls and fractures in elderly women with osteopenia. Despite a small sample size, the data also showed a promising effect of training on hip fractures. The strengths of the study include its design and long-term follow-up. The target population was a homogeneous, stable, and representative sample of older Finnish women obtained from the Finnish Population Register Centre, which has 100% coverage. The chosen exercise regimen is easily applicable at the population level. Randomized controlled trials have suggested, and systematic reviews have confirmed, that strength and balance training for healthy elderly people can reduce the risk of falls by 15% to 50%. 29 Previous systematic reviews of randomized controlled exercise trials reporting the number of fractures in elderly populations have failed to find evidence of the efficacy of exercise for preventing osteoporotic fractures. 30,31 A meta-analysis by Lock et al 31 evaluated the clinical effectiveness of 4 exercise trials in which the outcomes measured differed between trials: osteoporotic fractures at any site were reported in some trials, 33 and spine or wrist 33 fractures were found in other trials. Exercise was not associated with risk of fractures in that analysis. None of the included trials adequately reported the concealment of 1552

6 Table 3. Mean (95% CI) Values on Functional Ability Tests for Study Groups at Baseline and at 4 Years, 5 Years, and 6 Years of Follow-up and Mean (95% CI) Difference Between Groups a Test Exercise Group Control Group Difference P Value b Primary end points Postural sway, cm Baseline 11.9 (10.7 to 12.2) 12.1 (11.0 to 13.1) 0.2 ( 1.2 to 0.9)... 4 y 19.2 (18.0 to 21.2) 20.0 (17.5 to 21.1) 0.8 ( 2.7 to 1.2).72 5 y 19.0 (16.6 to 20.1) 22.2 (19.4 to 26.3) 3.2 ( 6.4 to 0.1).07 6 y 20.3 (16.9 to 21.2) 22.2 (16.1 to 26.2) 1.9 ( 6.4 to 2.6).48 Group time P value c.005 Postintervention group time P value d.06 Leg strength, kg Baseline 94.4 (86.9 to 101.8) 84.2 (77.3 to 90.8) 10.2 (0.4 to 20.4)... 4 y 84.4 (77.5 to 91.0) 73.8 (65.9 to 81.6) 10.6 (0.5 to 20.7).41 5 y 65.1 (60.6 to 69.7) 61.1 (55.1 to 67.0) 4.0 ( 3.1 to 11.3).49 6 y 68.9 (63.9 to 73.8) 63.5 (59.3 to 67.8) 5.4 ( 12.5 to 11.9).28 Group time P value c.001 Postintervention group time P value d.04 Secondary end points Walking speed, m/s Baseline 1.6 (1.6 to 1.7) 1.6 (1.6 to 1.8) 0.0 ( 0.1 to 0.1)... 4 y 1.7 (1.6 to 1.7) 1.6 (1.5 to 1.7) 0.1 ( 0.0 to 0.2) y 1.7 (1.6 to 1.8) 1.6 (1.5 to 1.8) 0.1 ( 0.1 to 0.2).02 6 y 1.7 (1.6 to 1.8) 1.6 (1.5 to 1.8) 0.1 ( 0.0 to 0.2).04 Group time P value c.001 Postintervention group time P value d.03 2-min walking test, m Baseline (148.7 to 165.1) (152.4 to 171.1) 0.1 ( 8.1 to 7.9)... 4 y (161.3 to 176.3) (160.0 to 180.2) 8.0 ( 2.9 to 18.9).15 5 y (158.1 to 174.0) (152.8 to 176.8) 3.7 ( 8.3 to 15.7).54 6 y (142.6 to 162.6) (134.8 to 166.3) 13.0 ( 2.9 to 28.9).06 Group time P value c.005 Postintervention group time P value d.06 TUG test score, s Baseline 10.1 (9.3 to 10.6) 10.7 (9.4 to 10.9) 0.6 ( 1.3 to 0.1)... 4 y 8.2 (7.7 to 8.6) 9.4 (7.7 to 8.8) 1.2 ( 2.6 to 0.1).18 5 y 7.7 (7.3 to 8.0) 7.9 (7.1 to 8.0) 0.2 ( 0.9 to 0.4).96 6 y 8.6 (8.0 to 9.3) 9.2 (7.6 to 9.8) 0.6 ( 1.7 to 0.5).83 Group time P value c.001 Postintervention group time P value d.04 FAI score Baseline 33.2 (32.3 to 35.2) 31.6 (30.8 to 33.7) 1.7 (0.5 to 2.8)... 4 y 32.3 (31.3 to 34.4) 29.2 (27.1 to 31.5) 3.2 (1.0 to 5.3).14 5 y 30.6 (30.0 to 32.9) 29.1 (27.4 to 31.1) 1.5 ( 0.6 to 3.5).95 6 y 32.5 (31.3 to 33.6) 30.5 (28.6 to 32.4) 1.7 (0.2 to 3.3).84 Group time P value c.001 Postintervention group time P value d.006 GDS score Baseline 5.9 (2.6 to 12.0) 6.7 (2.2 to 7.1) 0.9 ( 2.7 to 0.9)... 4 y 5.5 (2.6 to 9.2) 7.8 (2.5 to 9.2) 2.3 ( 4.5 to 0.2).51 5 y 5.3 (3.3 to 8.1) 7.6 (3.4 to 9.6) 2.8 ( 4.2 to 0.4).29 6 y 5.9 (1.3 to 6.4) 6.4 (2.8 to 8.5) 0.4 ( 2.3 to 1.4).76 Group time P value c.02 Postintervention group time P value d.02 MMSE score Baseline 27.0 (26.7 to 29.5) 27.1 (27.1 to 28.9) 0.2 ( 0.8 to 0.5)... 4 y 27.2 (26.3 to 28.8) 28.1 (27.4 to 29.3) 0.9 ( 2.2 to 0.4).49 5 y 27.3 (26.9 to 28.9) 27.3 (26.9 to 29.0) 0.1 ( 0.9 to 0.8).77 6 y 26.8 (26.0 to 28.7) 27.2 (27.0 to 29.0) 0.4 ( 1.3 to 0.6).79 Group time P value c.42 Postintervention group time P value d.19 Abbreviations: CI, confidence interval; FAI, Frenchay Activities Index; GDS, Geriatric Depression Scale; MMSE, Mini-Mental State Examination; TUG, Timed Up and Go. a Sample sizes were as follows: at baseline, n=84 in the exercise group and n=76 in the control group; at 4 years, n=64 in the exercise group and n=53 in the control group; at 5 years, n=53 in the exercise group and n=41 in the control group; and at 6 years, n=55 in the exercise group and n=45 in the control group. b Significance of the difference between changes from baseline in exercise and control groups, determined using independent-samples t test. c P value for the group time interaction using multiple linear regression analyses with generalized estimation equations adjusted for body mass index change from baseline, with all 7 repeated measurements included (baseline, 12 months, 24 months, 30 months, 4 years, 5 years, and 6 years). d P value for the group time interaction using multiple linear regression analyses with generalized estimation equations adjusted for body mass index change from baseline, with postintervention measurements included (4 years, 5 years, and 6 years). 1553

7 Table 4. Mean (95% CI) BMD and BMC at Different Proximal Femur Sites at Baseline and at 4 Years, 5 Years, and 6 Years of Follow-up and Mean (95% CI) Difference Between Groups Exercise Group (n=84) Control Group (n=76) Difference P Value a Neck BMD, g/cm 2 Baseline 0.67 (0.66 to 0.68) 0.67 (0.66 to 0.68) 0.00 ( 0.01 to 0.02)... 4 y 0.66 (0.64 to 0.67) 0.65 (0.64 to 0.67) 0.01 ( 0.02 to 0.03).27 5 y 0.65 (0.64 to 0.67) 0.66 (0.64 to 0.68) 0.01 ( 0.03 to 0.02).76 6 y 0.64 (0.62 to 0.66) 0.64 (0.63 to 0.65) 0.00 ( 0.02 to 0.02).44 Group time P value b.64 Postintervention group time P value c.87 Neck BMC, g Baseline 3.22 (3.14 to 3.30) 3.24 (3.16 to 3.32) 0.02 ( 0.13 to 0.09)... 4 y 3.21 (3.13 to 3.30) 3.23 (3.14 to 3.32) 0.01 ( 0.14 to 0.11).87 5 y 3.20 (3.11 to 3.29) 3.24 (3.14 to 3.33) 0.03 ( 0.16 to 0.09).68 6 y 3.18 (3.09 to 3.26) 3.18 (3.11 to 3.26) 0.01 ( 0.13 to 0.11).82 Group time P value b.56 Postintervention group time P value c.24 Trochanter BMD, g/cm 2 Baseline 0.62 (0.61 to 0.64) 0.62 (0.60 to 0.64) 0.00 ( 0.02 to 0.03)... 4 y 0.62 (0.60 to 0.64) 0.61 (0.59 to 0.63) 0.01 ( 0.02 to 0.03).24 5 y 0.62 (0.60 to 0.64) 0.61 (0.59 to 0.63) 0.01 ( 0.02 to 0.03).55 6 y 0.62 (0.60 to 0.63) 0.61 (0.59 to 0.62) 0.01 ( 0.02 to 0.04).43 Group time P value b.66 Postintervention group time P value c.84 Trochanter BMC, g Baseline 8.08 (7.74 to 8.42) 8.45 (8.04 to 8.86) 0.37 ( 0.90 to 0.16)... 4 y 7.87 (7.51 to 8.23) 8.09 (7.66 to 8.52) 0.22 ( 0.87 to 0.23).24 5 y 7.84 (7.47 to 8.21) 8.13 (7.70 to 8.57) 0.30 ( 0.51 to 0.60).57 6 y 7.76 (7.39 to 8.14) 8.01 (7.56 to 8.46) 0.25 ( 0.78 to 0.33).47 Group time P value b.14 Postintervention group time P value c.15 Total proximal femur BMD, g/cm 2 Baseline 0.75 (0.73 to 0.76) 0.73 (0.72 to 0.75) 0.01 ( 0.01 to 0.04)... 4 y 0.74 (0.72 to 0.76) 0.73 (0.71 to 0.74) 0.01 ( 0.01 to 0.04).66 5 y 0.74 (0.72 to 0.75) 0.73 (0.71 to 0.75) 0.01 ( 0.02 to 0.03).79 6 y 0.73 (0.72 to 0.75) 0.72 (0.71 to 0.74) 0.01 ( 0.01 to 0.04).72 Group time P value b.37 Postintervention group time P value c.65 Total proximal femur BMC, g Baseline (23.15 to 24.55) (23.49 to 25.04) 0.42 ( 1.45 to 0.62)... 4 y (22.80 to 24.40) (23.15 to 24.85) 0.01 ( 1.56 to 0.76).40 5 y (22.77 to 24.47) (23.21 to 25.01) 0.01 ( 1.72 to 0.74).57 6 y (22.37 to 24.16) (22.82 to 24.58) 0.01 ( 1.68 to 0.81).48 Group time P value b.36 Postintervention group time P value c.24 Abbreviations: BMC, bone mineral content; BMD, bone mineral density; CI, confidence interval. a Significance of the difference between changes from baseline in exercise and control groups, determined using independent-sample t test. b P value for the group time interaction using multiple linear regression analyses with generalized estimation equations adjusted for body mass index change from baseline, calcium intake, and use of osteoporosis medication, with all 6 repeated measurements included (baseline, 12 months, 30 months, 4 years, 5 years, and 6 years). c P value for the group time interaction using multiple linear regression analyses with generalized estimation equations adjusted for body mass index change from baseline, calcium intake, and use of osteoporosis medication, with postintervention measurements included (4 years, 5 years, and 6 years). allocation of participants to treatment arms, and only 2 trials 32,34,35 reported masking of the outcome assessor. Only 1 trial 34,35 described participants who withdrew from treatment. To our knowledge, our study is the first to report the long-term effect of exercise on fractures in elderly women with osteopenia. Our results are in concordance with an up-to-date review including the most recent high-quality trials. 7 The authors concluded that exercise can reduce falls, fall-related fractures, and several risk factors for falls in individuals with low BMD. Our data also confirm the promising results of prospective observational cohort studies showing that moderate lifelong physical activity is associated with a reduced risk of fragility fractures in elderly women. 9,10 However, the best evidence for the effect of exercise in preventing fragility fractures would be to conduct several population-based randomized controlled trials in individuals with osteopenia with fractures as an end point. So far there have been no such trials, and more high-quality randomized controlled trials recording fractures at all sites are needed to evaluate the effect of exercise on risk of fractures. The fractures were located more proximally in the control group than in the exercise group, indicating that the type of fall may have been different in the exercisers. Forces applied to the hip during a fall depend on the fall characteristics, self- 1554

8 protective responses, and thickness of soft tissues overlying the hip. 36 During the trial, the women in the exercise group had a significant improvement in many physiological characteristics that may have modified the fall dynamics and improved additional absorptive mechanisms. Hip fracture is easy to diagnose, and practically all hip fractures require hospital treatment. Therefore, the hospital discharge registers are a good source for the identification of patients with hip fracture in Finland. However, a potential bias in using hospital discharge records is related to multiple hospitalizations of a single patient and possible readmissions due to the same fracture. To avoid this bias, fractures in all original 1689 women were confirmed from patient records manually in Data on fractures were collected only from hospital admissions, which for some fracture types (such as vertebral and wrist fractures) represent only a proportion of the fractures in that population. However, it is unlikely that the treatment of fractures was dependent on group assignment in this study, and our results are not unbiased in regard to the effect of exercise on risk of fracture. Each activity of daily living, such as rising from bed, requires a certain amount of postural control and strength. Many elderly people live just beyond the threshold of the capacity needed for such tasks. The reserve in performance capacity may be so slight that even a small additional decline in balance or strength can cause serious difficulties. On the contrary, a minor increase in capacity may help maintain independence. To be able to move about their residences and communities, elderly people should be able to walk 300 m. The speed required to cross the street safely has been suggested as 1.1 m/s, 37 and a walking speed of 1 m/s or less was shown to be indicative of poor health outcomes. 38 Those who perform the TUG test in less than 20 seconds appear to be able to go outside alone safely. 25 In our study, the chosen exercise regimen had no effect on BMD or BMC. However, the women in the exercise group preserved their gait speed, postural control, and functional ability and had fewer fractures compared with the women in the control group. Change in gait speed was the only significant independent predictor of fracture incidence rate. These results suggest that these women may have had an increase in performance capacity reserve large enough to prevent loss of independence and future fractures. We also found a significant decrease in all-cause mortality within the exercise group. In observational studies, physical activity has been shown to reduce all-cause mortality in elderly women, 39,40 and there seems to be an inverse linear dose-response relationship between the volume of physical activity and all-cause mortality. However, the small sample size limits the conclusions that can be drawn in this study. Several limitations in our study need to be considered. Of the 1689 originally eligible women, 467 (27.6%) did not participate in the study. These women seemed to be the frailest group in our cohort. Of the nonparticipants, 194 women (41.5%) died during follow-up, which is a significantly higher mortality rate than in the participants. Hip fractures were also more common in the nonparticipants than in the participants. Therefore, the results of this study cannot be generalized to very ill or institutionalized elderly people. To make these observations more generalizable, the findings must be replicated in institutionalized women and other age groups of women. In the exercise trial, it was not possible for obvious reasons to mask patients to the intervention. Finally, because of incomplete information on falls and physical activity during the postintervention period, these data were not reported. In conclusion, 30 months of supervised, mainly home-based exercises followed by voluntary home training had a positive long-term effect on balance and gait in high-risk elderly women. The exercise program also seemed to decrease the risk of hip fracture. Lifelong physical activity was associated with reduced risk of fractures. Furthermore, mortality was significantly lower in the exercise group than in the control group during the extended follow-up period. Regular daily physical activity should be recommended to elderly women with osteopenia. Accepted for Publication: February 12, Correspondence: Raija Korpelainen, PhD, Department of Sports and Exercise Medicine, Oulu Deaconess Institute, Kajaaninkatu 17, Oulu, Finland Author Contributions: Drs R. Korpelainen, Nieminen, and J. Korpelainen had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: R. Korpelainen, Keinänen-Kiukaanniemi, Väänänen, and J. Korpelainen. Acquisition of data: R. Korpelainen, Heikkinen, and J. Korpelainen. Analysis and interpretation of data: R. Korpelainen, Keinänen- Kiukaanniemi, Nieminen, and J. Korpelainen. Drafting of the manuscript: R. Korpelainen, Keinänen-Kiukaanniemi, and Nieminen. Critical revision of the manuscript for important intellectual content: Keinänen-Kiukaanniemi, Nieminen, Heikkinen, Väänänen, and J. Korpelainen. Statistical analysis: R. Korpelainen and Nieminen. Obtained funding: R. Korpelainen and Väänänen. Administrative, technical, and material support: Keinänen- Kiukaanniemi and J. Korpelainen. Study supervision: Keinänen-Kiukaanniemi, Heikkinen, and Väänänen. Financial Disclosure: None reported. Funding/Support: This study was funded by the Finnish Ministry of Education, the Finnish Cultural Foundation, the Juho Vainio Foundation, the Miina Sillanpää Foundation, the Research Foundation of Orion Corporation, and the Northern Ostrobothnia District Hospital. Role of the Sponsors: The sponsors of the study had no role in the design or conduct of the study; the collection, analysis, or interpretation of the data; or the drafting of the manuscript. REFERENCES 1. Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C. Excess mortality following hip fracture: a systematic epidemiological review [published online ahead of print May 7, 2009]. Osteoporos Int. 2009;20(10): doi: /s Holt G, Smith R, Duncan K, Hutchison JD, Gregori A. Gender differences in epi- 1555

9 demiology and outcome after hip fracture: evidence from the Scottish Hip Fracture Audit. J Bone Joint Surg Br. 2008;90(4): Cree M, Soskolne CL, Belseck E, et al. Mortality and institutionalization following hip fracture. J Am Geriatr Soc. 2000;48(3): Johnell O, Kanis JA, Odén A, et al. Mortality after osteoporotic fractures. Osteoporos Int. 2004;15(1): Youm T, Koval KJ, Kummer FJ, Zuckerman JD. Do all hip fractures result from a fall? Am J Orthop (Belle Mead NJ). 1999;28(3): Sherrington C, Whitney JC, Lord SR, Herbert RD, Cumming RG, Close JC. Effective exercise for the prevention of falls: a systematic review and meta-analysis. J Am Geriatr Soc. 2008;56(12): de Kam D, Smulders E, Weerdesteyn V, Smits-Engelsman BC. Exercise interventions to reduce fall-related fractures and their risk factors in individuals with low bone density: a systematic review of randomized controlled trials [published online ahead of print May 7, 2009]. Osteoporos Int. 2009;20(12): doi: /s Chang JT, Morton SC, Rubenstein LZ, et al. Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ. 2004;328(7441):680. doi: /bmj Joakimsen RM, Magnus JH, Fønnebø V. Physical activity and predisposition for hip fractures: a review. Osteoporos Int. 1997;7(6): Høidrup S, Sørensen TI, Strøger U, Lauritzen JB, Schroll M, Grønbaek M. Leisuretime physical activity levels and changes in relation to risk of hip fracture in men and women. Am J Epidemiol. 2001;154(1): Gregg EW, Pereira MA, Caspersen CJ. Physical activity, falls, and fractures among older adults: a review of the epidemiologic evidence. J Am Geriatr Soc. 2000; 48(8): Feskanich D, Willett W, Colditz G. Walking and leisure-time activity and risk of hip fracture in postmenopausal women. JAMA. 2002;288(18): Korpelainen R, Keinänen-Kiukaanniemi S, Heikkinen J, Väänänen K, Korpelainen J. Effect of impact exercise on bone mineral density in elderly women with low BMD: a population-based randomized controlled 30-month intervention. Osteoporos Int. 2006;17(1): Korpelainen R, Keinänen-Kiukaanniemi S, Heikkinen J, Väänänen K, Korpelainen J. Effect of exercise on extraskeletal risk factors for hip fractures in elderly women with low BMD: a population-based randomized controlled trial. J Bone Miner Res. 2006;21(5): Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, Evans WJ. Highintensity strength training in nonagenarians: effects on skeletal muscle. JAMA. 1990;263(22): Lord SR, Ward JA, Williams P, Strudwick M. The effect of a 12-month exercise trial on balance, strength, and falls in older women: a randomized controlled trial. J Am Geriatr Soc. 1995;43(11): Lord SR, Ward JA, Williams P. Exercise effect on dynamic stability in older women: a randomized controlled trial. Arch Phys Med Rehabil. 1996;77(3): DeVito CA, Morgan RO, Duque M, Abdel-Moty E, Virnig BA. Physical performance effects of low-intensity exercise among clinically defined high-risk elders. Gerontology. 2003;49(3): Liu-Ambrose T, Eng JJ, Khan KM, Carter ND, McKay HA. Older women with osteoporosis have increased postural sway and weaker quadriceps strength than counterparts with normal bone mass: overlooked determinants of fracture risk? J Gerontol A Biol Sci Med Sci. 2003;58(9):M862-M Korpelainen R, Korpelainen J, Heikkinen J, Väänänen K, Keinänen-Kiukaanniemi S. Lifestyle factors are associated with osteoporosis in lean women but not in normal and overweight women: a population-based cohort study of 1222 women. Osteoporos Int. 2003;14(1): Lüthje P, Nurmi I, Kataja M, Heliövaara M, Santavirta S. Incidence of pelvic fractures in Finland in Acta Orthop Scand. 1995;66(3): Carter J, Mant F, Mant J, Wade D, Winner S. Comparison of postal version of the Frenchay Activities Index with interviewer-administered version for use in people with stroke. Clin Rehabil. 1997;11(2): Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res ; 17(1): Folstein MF, Folstein SE, McHugh PR. Mini-Mental State : a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3): Podsiadlo D, Richardson S. The timed Up & Go : a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2): Frändin K, Grimby G. Assessment of physical activity, fitness and performance in 76-year-olds. Scand J Med Sci Sports. 1994;4: Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12- minute walking tests in respiratory disease. Br Med J (Clin Res Ed). 1982;284 (6329): Twisk J, de Vente W. Attrition in longitudinal studies: how to deal with missing data. J Clin Epidemiol. 2002;55(4): Kannus P, Sievänen H, Palvanen M, Järvinen T, Parkkari J. Prevention of falls and consequent injuries in elderly people. Lancet. 2005;366(9500): Kanis JA, Johnell O, Oden A, De Laet C, Jonsson B, Dawson A. Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies. Bone. 2002;30(1): Lock CA, Lecouturier J, Mason JM, Dickinson HO. Lifestyle interventions to prevent osteoporotic fractures: a systematic review. Osteoporos Int. 2006;17(1): Ebrahim S, Thompson PW, Baskaran V, Evans K. Randomized placebo-controlled trial of brisk walking in the prevention of postmenopausal osteoporosis. Age Ageing. 1997;26(4): Preisinger E, Alacamlioglu Y, Pils K, et al. Exercise therapy for osteoporosis: results of a randomised controlled trial. Br J Sports Med. 1996;30(3): Sinaki M, Wahner HW, Offord KP, Hodgson SF. Efficacy of nonloading exercises in prevention of vertebral bone loss in postmenopausal women: a controlled trial. Mayo Clin Proc. 1989;64(7): Sinaki M, Itoi E, Wahner HW, et al. Stronger back muscles reduce the incidence of vertebral fractures: a prospective 10 year follow-up of postmenopausal women. Bone. 2002;30(6): Bouxsein ML, Szulc P, Munoz F, Thrall E, Sornay-Rendu E, Delmas PD. Contribution of trochanteric soft tissues to fall force estimates, the factor of risk, and prediction of hip fracture risk. J Bone Miner Res. 2007;22(6): Shumway-Cook A, Woollacott MH. Motor Control: Theory and Practical Applications. Baltimore, MD: Williams & Wilkins; Cesari M, Kritchevsky SB, Penninx BW, et al. Prognostic value of usual gait speed in well-functioning older people: results from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2005;53(10): Oguma Y, Sesso HD, Paffenbarger RS Jr, Lee IM. Physical activity and all cause mortality in women: a review of the evidence. Br J Sports Med. 2002;36(3): Lee IM, Skerrett PJ. Physical activity and all-cause mortality: what is the doseresponse relation? Med Sci Sports Exerc. 2001;33(6)(suppl):S459-S471, discussion S493-S

The Risks of Hip Fracture in Older People from Private Homes and Institutions

The Risks of Hip Fracture in Older People from Private Homes and Institutions Age and Ageing 1996:25:381-385 The Risks of Hip Fracture in Older People from Private Homes and Institutions MEG BUTLER, ROBYN NORTON, TREVOR LEE-JOE, ADA CHENG, A. JOHN CAMPBELL Summary This study aimed

More information

Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India

Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India International Journal of Public Health Science (IJPHS) Vol.3, No.4, December 2014, pp. 276 ~ 280 ISSN: 2252-8806 276 Body Mass Index as Predictor of Bone Mineral Density in Postmenopausal Women in India

More information

Radhika Patil¹, Kirsti Uusi-Rasi 1,2, Kari Tokola¹, Pekka Kannus 1,3,4, Saija Karinkanta 1, Harri Sievänen 1 IFA

Radhika Patil¹, Kirsti Uusi-Rasi 1,2, Kari Tokola¹, Pekka Kannus 1,3,4, Saija Karinkanta 1, Harri Sievänen 1 IFA Effects of a multi-component exercise program on physical function and falls among older women: a two-year community-based, randomized controlled trial Radhika Patil¹, Kirsti Uusi-Rasi 1,2, Kari Tokola¹,

More information

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN October 2-4, Liverpool, UK EURO SPINE 2013 DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN D. Colangelo, L. A. Nasto, M. Mormando, E.

More information

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm Interpreting DEXA Scan and the New Fracture Risk Assessment Algorithm Prof. Samir Elbadawy *Osteoporosis affect 30%-40% of women in western countries and almost 15% of men after the age of 50 years. Osteoporosis

More information

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk Dr Tuan V NGUYEN Bone and Mineral Research Program, Garvan Institute of Medical Research, Sydney NSW Mapping Translational Research into Individualised Prognosis of Fracture Risk From the age of 60, one

More information

The Deconditioned Elderly Patient: Have We Been Getting it Wrong? By: Ernest Roy PT, DPT

The Deconditioned Elderly Patient: Have We Been Getting it Wrong? By: Ernest Roy PT, DPT The Deconditioned Elderly Patient: Have We Been Getting it Wrong? By: Ernest Roy PT, DPT The Debilitated Patient A review of outcomes for > 84,000 patients over 65 y/o revealed: Rate of functional recovery

More information

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment William D. Leslie, MD MSc FRCPC Case #1 Age 53: 3 years post-menopause Has always enjoyed excellent health with

More information

Fractures: Epidemiology and Risk Factors. July 2012 CME (35 minutes) 7/24/ July12 1. Osteoporotic fractures: Comparison with other diseases

Fractures: Epidemiology and Risk Factors. July 2012 CME (35 minutes) 7/24/ July12 1. Osteoporotic fractures: Comparison with other diseases Financial Disclosures Fractures: Epidemiology and Risk Factors Research grants, speaking or consulting: Amgen, Lilly, Merck, Novartis, Radius Dennis M. Black, PhD Department of Epidemiology and Biostatistics

More information

Skeletal Manifestations

Skeletal Manifestations Skeletal Manifestations of Metabolic Bone Disease Mishaela R. Rubin, MD February 21, 2008 The Three Ages of Women Gustav Klimt 1905 1 Lecture Outline Osteoporosis epidemiology diagnosis secondary causes

More information

VERTEBRAL DEFORMITY IN PATIENTS with osteoporosis

VERTEBRAL DEFORMITY IN PATIENTS with osteoporosis ORIGINAL ARTICLE Effects of Reducing Resistance, Repetitions, and Frequency of Back-Strengthening Exercise in Healthy Young Women: A Pilot Study Michio Hongo, MD, Eiji Itoi, MD, Mehrsheed Sinaki, MD, Yoichi

More information

ASJ. How Many High Risk Korean Patients with Osteopenia Could Overlook Treatment Eligibility? Asian Spine Journal. Introduction

ASJ. How Many High Risk Korean Patients with Osteopenia Could Overlook Treatment Eligibility? Asian Spine Journal. Introduction Asian Spine Journal Asian Spine Clinical Journal Study Asian Spine J 2014;8(6):729-734 High http://dx.doi.org/10.4184/asj.2014.8.6.729 risk patients with osteopenia How Many High Risk Korean Patients with

More information

Building Bone Density-Research Issues

Building Bone Density-Research Issues Building Bone Density-Research Issues Helping to Regain Bone Density QUESTION 1 What are the symptoms of Osteoporosis? Who is at risk? Symptoms Bone Fractures Osteoporosis 1,500,000 fractures a year Kyphosis

More information

Bone Mineral Density and Its Associated Factors in Naresuan University Staff

Bone Mineral Density and Its Associated Factors in Naresuan University Staff Naresuan University Journal 2005; 13(3): 13-18 13 Bone Mineral Density and Its Associated Factors in Naresuan University Staff Supawitoo Sookpeng *, Patsuree Cheebsumon, Malinee Dhanarun, Thanyavee Pengpan

More information

Effectiveness of passive and active knee joint mobilisation following total knee arthroplasty: Continuous passive motion vs. sling exercise training.

Effectiveness of passive and active knee joint mobilisation following total knee arthroplasty: Continuous passive motion vs. sling exercise training. Effectiveness of passive and active knee joint mobilisation following total knee arthroplasty: Continuous passive motion vs. sling exercise training. Mau-Moeller, A. 1,2, Behrens, M. 2, Finze, S. 1, Lindner,

More information

Discovering prior fractures in your postmenopausal patient may be the LINK to reducing her fragility fracture* risk in the future.

Discovering prior fractures in your postmenopausal patient may be the LINK to reducing her fragility fracture* risk in the future. Discovering prior fractures in your postmenopausal patient may be the LINK to reducing her fragility fracture* risk in the future. *A fragility fracture is defined as a fracture caused by minimal trauma,

More information

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study Rheumatol Int (2006) 26: 427 431 DOI 10.1007/s00296-005-0004-4 ORIGINAL ARTICLE J. D. Ringe Æ H. Faber Æ P. Farahmand Æ A. Dorst Efficacy of risedronate in men with primary and secondary osteoporosis:

More information

Osteoporosis. Overview

Osteoporosis. Overview v2 Osteoporosis Overview Osteoporosis is defined as compromised bone strength that increases risk of fracture (NIH Consensus Conference, 2000). Bone strength is characterized by bone mineral density (BMD)

More information

Can we improve the compliance to prevention treatment after a wrist fracture? Roy Kessous

Can we improve the compliance to prevention treatment after a wrist fracture? Roy Kessous Can we improve the compliance to prevention treatment after a wrist fracture? Roy Kessous Distal radius fracture in women after menopause is in many cases a first clinical indication for the presence of

More information

Assessment and Treatment of Osteoporosis Professor T.Masud

Assessment and Treatment of Osteoporosis Professor T.Masud Assessment and Treatment of Osteoporosis Professor T.Masud Nottingham University Hospitals NHS Trust University of Nottingham University of Derby University of Southern Denmark What is Osteoporosis? Osteoporosis

More information

Fall-related risk factors and osteoporosis in older women referred to an open access bone densitometry service

Fall-related risk factors and osteoporosis in older women referred to an open access bone densitometry service Age and Ageing 05; 34: 67 71 Age and Ageing Vol. 34 No. 1 British Geriatrics Society 04; all rights reserved doi:10.1093/ageing/afh238 Published electronically 15 November 04 Fall-related risk factors

More information

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA

Challenging the Current Osteoporosis Guidelines. Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Challenging the Current Osteoporosis Guidelines Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA Whom to screen Which test How to diagnose Whom to treat Benefits

More information

International Journal of Health Sciences and Research ISSN:

International Journal of Health Sciences and Research  ISSN: International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Osteoporosis- Do We Need to Think Beyond Bone Mineral Density? Dr Preeti Soni 1, Dr Shipra

More information

HEALTH-RELATED QUALITY OF LIFE AFTER HIP FRACTURE IN THE ELDERLY COMMUNITY-DWELLING

HEALTH-RELATED QUALITY OF LIFE AFTER HIP FRACTURE IN THE ELDERLY COMMUNITY-DWELLING HEALTH-RELATED QUALITY OF LIFE AFTER HIP FRACTURE IN THE ELDERLY COMMUNITY-DWELLING Jithathai Jongjit 1, Ladda Komsopapong 1, Pramook Songjakkaew 1 and Ronnachai Kongsakon 2 1 Department of Rehabilitation

More information

Men and Osteoporosis So you think that it can t happen to you

Men and Osteoporosis So you think that it can t happen to you Men and Osteoporosis So you think that it can t happen to you Jonathan D. Adachi MD, FRCPC Alliance for Better Bone Health Chair in Rheumatology Professor, Department of Medicine Michael G. DeGroote School

More information

Fractures: Epidemiology and Risk Factors. Osteoporosis in Men (more this afternoon) 1/5 men over age 50 will suffer osteoporotic fracture 7/16/2009

Fractures: Epidemiology and Risk Factors. Osteoporosis in Men (more this afternoon) 1/5 men over age 50 will suffer osteoporotic fracture 7/16/2009 Fractures: Epidemiology and Risk Factors Mary L. Bouxsein, PhD Department of Orthopaedic Surgery Beth Israel Deaconess Medical Center Harvard Medical School, Boston, MA Outline Fracture incidence and impact

More information

Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA

Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA ORIGINAL ARTICLE Comparison of Bone Density of Distal Radius With Hip and Spine Using DXA Leila Amiri 1, Azita Kheiltash 2, Shafieh Movassaghi 1, Maryam Moghaddassi 1, and Leila Seddigh 2 1 Rheumatology

More information

O. Bruyère M. Fossi B. Zegels L. Leonori M. Hiligsmann A. Neuprez J.-Y. Reginster

O. Bruyère M. Fossi B. Zegels L. Leonori M. Hiligsmann A. Neuprez J.-Y. Reginster DOI 10.1007/s00296-012-2460-y ORIGINAL ARTICLE Comparison of the proportion of patients potentially treated with an anti-osteoporotic drug using the current criteria of the Belgian national social security

More information

Long-term Effect of Physical Activity Counseling on Mobility Limitation Among Older People: A Randomized Controlled Study

Long-term Effect of Physical Activity Counseling on Mobility Limitation Among Older People: A Randomized Controlled Study Journal of Gerontology: MEDICAL SCIENCES The Author 2009. Published by Oxford University Press on behalf of The Gerontological Society of America. Cite journal as: J Gerontol A Biol Sci Med Sci All rights

More information

Osteoporosis Screening and Treatment in Type 2 Diabetes

Osteoporosis Screening and Treatment in Type 2 Diabetes Osteoporosis Screening and Treatment in Type 2 Diabetes Ann Schwartz, PhD! Dept. of Epidemiology and Biostatistics! University of California San Francisco! October 2011! Presenter Disclosure Information

More information

Horizon Scanning Centre March Denosumab for glucocorticoidinduced SUMMARY NIHR HSC ID: 6329

Horizon Scanning Centre March Denosumab for glucocorticoidinduced SUMMARY NIHR HSC ID: 6329 Horizon Scanning Centre March 2014 Denosumab for glucocorticoidinduced osteoporosis SUMMARY NIHR HSC ID: 6329 This briefing is based on information available at the time of research and a limited literature

More information

Current Issues in Osteoporosis

Current Issues in Osteoporosis Current Issues in Osteoporosis California AACE 18TH Annual Meeting & Symposium Marina del Rey, CA September 15, 2018 Michael R. McClung, MD, FACP,FACE Director, Oregon Osteoporosis Center Portland, Oregon,

More information

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS 4:30-5:15pm Ask the Expert: Osteoporosis SPEAKERS Silvina Levis, MD OSTEOPOROSIS - FACTS 1:3 older women and 1:5 older men will have a fragility fracture after age 50 After 3 years of treatment, depending

More information

Title. CitationAustralasian Journal on Ageing, 31(3): Issue Date Doc URL. Rights. Type. File Information

Title. CitationAustralasian Journal on Ageing, 31(3): Issue Date Doc URL. Rights. Type. File Information Title Randomised controlled pilot study in Japan comparing with a home visit with conversation alone Ukawa, Shigekazu; Yuasa, Motoyuki; Ikeno, Tamiko; Yo Author(s) Kishi, Reiko CitationAustralasian Journal

More information

Gait abnormalities as early signs of MCI

Gait abnormalities as early signs of MCI Demensfondens forskningsstipendier Anna Nordström Gait abnormalities as early signs of MCI With aim To evaluate spatiotemporal gait parameters as predictor of mild cognitive impairment (MCI) in A population

More information

Screening for absolute fracture risk using FRAX tool in men and women within years in urban population of Puducherry, India

Screening for absolute fracture risk using FRAX tool in men and women within years in urban population of Puducherry, India International Journal of Research in Orthopaedics Firoz A et al. Int J Res Orthop. 217 Sep;3(5):151-156 http://www.ijoro.org Original Research Article DOI: http://dx.doi.org/1.1823/issn.2455-451.intjresorthop21739

More information

Coordinator of Post Professional Programs Texas Woman's University 1

Coordinator of Post Professional Programs Texas Woman's University 1 OSTEOPOROSIS Update 2007-2008 April 26, 2008 How much of our BMD is under our control (vs. genetics)? 1 2 Genetic effects on bone loss: longitudinal twin study (Makovey, 2007) Peak BMD is under genetic

More information

Risk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study

Risk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study Risk Factors for Postmenopausal Fractures What We Have Learned from The OSTPRE - study Heikki Kröger Kuopio Musculoskeletal Research Unit, University of Eastern Finland (UEF) Dept. of Orthopaedics, Traumatology

More information

Disclosures. Diagnostic Challenges in Osteoporosis: Whom To Treat 9/25/2014

Disclosures. Diagnostic Challenges in Osteoporosis: Whom To Treat 9/25/2014 Disclosures Diagnostic Challenges in Osteoporosis: Whom To Treat Ethel S. Siris, MD Columbia University Medical Center New York, NY Consultant on scientific issues for: AgNovos Amgen Eli Lilly Merck Novartis

More information

Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck

Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Consulting: Merck Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Outline Fracture incidence and impact of fractures

More information

Disclosures Fractures:

Disclosures Fractures: Disclosures Fractures: A. Schwartz Epidemiology and Risk Factors Research Funding: GlaxoSmithKline, Merck Ann V. Schwartz, PhD Department of Epidemiology and Biostatistics UCSF Outline Fracture incidence

More information

NIH Public Access Author Manuscript Osteoporos Int. Author manuscript; available in PMC 2011 January 8.

NIH Public Access Author Manuscript Osteoporos Int. Author manuscript; available in PMC 2011 January 8. NIH Public Access Author Manuscript Published in final edited form as: Osteoporos Int. 2011 January ; 22(1): 345 349. doi:10.1007/s00198-010-1179-4. Does Dietary Protein Reduce Hip Fracture Risk in Elders?

More information

Oral Alendronate Vs. Three-Monthly Iv Ibandronate In The Treatment Of Postmenopausal Osteoporosis

Oral Alendronate Vs. Three-Monthly Iv Ibandronate In The Treatment Of Postmenopausal Osteoporosis Oral Alendronate Vs. Three-Monthly Iv Ibandronate In The Treatment Of Postmenopausal Osteoporosis Miriam Silverberg A. Study Purpose and Rationale More than 70% of fractures in people after the age of

More information

ORIGINAL INVESTIGATION. Continuously Increasing Number and Incidence of Fall-Induced, Fracture-Associated, spinal cord injuries in older persons

ORIGINAL INVESTIGATION. Continuously Increasing Number and Incidence of Fall-Induced, Fracture-Associated, spinal cord injuries in older persons ORIGINAL INVESTIGATION Continuously Increasing Number and of Fall-Induced, Fracture-Associated, Spinal Cord Injuries in Elderly Persons Pekka Kannus, MD, PhD; Seppo Niemi; Mika Palvanen, MD; Jari Parkkari,

More information

Effect of Precision Error on T-scores and the Diagnostic Classification of Bone Status

Effect of Precision Error on T-scores and the Diagnostic Classification of Bone Status Journal of Clinical Densitometry, vol. 10, no. 3, 239e243, 2007 Ó Copyright 2007 by The International Society for Clinical Densitometry 1094-6950/07/10:239e243/$32.00 DOI: 10.1016/j.jocd.2007.03.002 Original

More information

Setting The setting was primary care. The economic study was carried out in the USA.

Setting The setting was primary care. The economic study was carried out in the USA. Universal bone densitometry screening combined with alendronate therapy for those diagnosed with osteoporosis is highly cost-effective for elderly women Schousboe J T, Ensrud K E, Nyman J A, Melton L J,

More information

Prevention of osteoporosis: cost-effectiveness of different pharmaceutical treatments Ankjaer-Jensen A, Johnell O

Prevention of osteoporosis: cost-effectiveness of different pharmaceutical treatments Ankjaer-Jensen A, Johnell O Prevention of osteoporosis: cost-effectiveness of different pharmaceutical treatments Ankjaer-Jensen A, Johnell O Record Status This is a critical abstract of an economic evaluation that meets the criteria

More information

Increased mortality after fracture of the surgical neck of the humerus: a case-control study of 253 patients with a 12-year follow-up.

Increased mortality after fracture of the surgical neck of the humerus: a case-control study of 253 patients with a 12-year follow-up. Increased mortality after fracture of the surgical neck of the humerus: a case-control study of 253 patients with a 12-year follow-up. Olsson, Christian; Petersson, Claes; Nordquist, Anders Published in:

More information

The New England Journal of Medicine

The New England Journal of Medicine The New England Journal of Medicine Copyright, 2000, by the Massachusetts Medical Society VOLUME 343 N OVEMBER 23, 2000 NUMBER 21 PREVENTION OF HIP FRACTURE IN ELDERLY PEOPLE WITH USE OF A HIP PROTECTOR

More information

Chapter 39: Exercise prescription in those with osteoporosis

Chapter 39: Exercise prescription in those with osteoporosis Chapter 39: Exercise prescription in those with osteoporosis American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York:

More information

Documentation, Codebook, and Frequencies

Documentation, Codebook, and Frequencies Documentation, Codebook, and Frequencies Dual-Energy X-ray Absorptiometry Femur Bone Measurements Examination Survey Years: 2005 to 2006 SAS Transport File: DXXFEM_D.XPT January 2009 NHANES 2005 2006 Data

More information

Chapter 17: Body Composition Status and Assessment

Chapter 17: Body Composition Status and Assessment Chapter 17: Body Composition Status and Assessment American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York: Lippincott,

More information

Risedronate prevents hip fractures, but who should get therapy?

Risedronate prevents hip fractures, but who should get therapy? INTERPRETING KEY TRIALS CHAD L. DEAL, MD Head, Center for Osteoporosis and Metabolic Bone Disease, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic THE HIP TRIAL Risedronate prevents

More information

An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines

An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines Osteoporos Int (2006) 17: 1111 1115 DOI 10.1007/s00198-006-0101-6 SHORT COMMUNICATION An audit of bone densitometry practice with reference to ISCD, IOF and NOF guidelines R. Baddoura. H. Awada. J. Okais.

More information

Functional Ability Screening Tools for the Clinic

Functional Ability Screening Tools for the Clinic Functional Ability Screening Tools for the Clinic Shelley Hockensmith,, P.T., NCS Objectives Review screening tools for physical or functional ability including Five Times Sit to Stand, Walking Speed,

More information

What Is FRAX & How Can I Use It?

What Is FRAX & How Can I Use It? What Is FRAX & How Can I Use It? Jacqueline Osborne PT, DPT Board Certified Geriatric Clinical Specialist Certified Exercise Expert for the Aging Adult Brooks Rehabilitation; Jacksonville, FL Florida Physical

More information

Risk factors for falls

Risk factors for falls Part I Risk factors for falls 1 Epidemiology of falls and fall-related injuries In this chapter, we examine the epidemiology of falls in older people. We review the major studies that have described the

More information

BONE HEALTH Dr. Tia Lillie. Exercise, Physical Activity and Osteoporosis

BONE HEALTH Dr. Tia Lillie. Exercise, Physical Activity and Osteoporosis BONE HEALTH Dr. Tia Lillie Exercise, Physical Activity and Osteoporosis Food for thought... How old would you be if you didn t know how old you were? DEFINITION: Osteoporosis Osteoporosis (OP) is a disease

More information

Osteoporosis is a disease in which bones become fragile

Osteoporosis is a disease in which bones become fragile Preventing Osteoporosis the Bone Estrogen Strength Training Way by Linda B. Houtkooper, Ph.D., R.D., FACSM, Vanessa A. Stanford, M.S., R.D., CSCS, Lauve L. Metcalfe, M.S., FAWHP, Timothy G. Lohman, Ph.D.,

More information

Study of the Association between Serum Vitamin D 25(OH) D levels, Muscle Strength and fall among Elderly.

Study of the Association between Serum Vitamin D 25(OH) D levels, Muscle Strength and fall among Elderly. DOI: 10.21276/aimdr.2017.3.2.ME7 Original Article ISSN (O):2395-2822; ISSN (P):2395-2814 Study of the Association between Serum Vitamin D 25(OH) D levels, Muscle Strength and fall among Elderly. Karthik

More information

Osteoporosis. Original Article. Positive Effects of Physiotherapy on Chronic Pain and Performance in. Osteoporosis. International

Osteoporosis. Original Article. Positive Effects of Physiotherapy on Chronic Pain and Performance in. Osteoporosis. International Osteoporos Int (1998) 8:21 221 ß 1998 European Foundation for Osteoporosis and the National Osteoporosis Foundation Osteoporosis International Original Article Positive Effects of Physiotherapy on Chronic

More information

The health economics of calcium and vitamin D3 for the prevention of osteoporotic hip fractures in Sweden Willis M S

The health economics of calcium and vitamin D3 for the prevention of osteoporotic hip fractures in Sweden Willis M S The health economics of calcium and vitamin D3 for the prevention of osteoporotic hip fractures in Sweden Willis M S Record Status This is a critical abstract of an economic evaluation that meets the criteria

More information

Top: Healthy Vertebrae Above: Osteoporotic bone

Top: Healthy Vertebrae Above: Osteoporotic bone Top: Healthy Vertebrae Above: Osteoporotic bone 2 OSTEOPOROSIS IS A DISEASE OF THE BONES, WHICH LEADS TO AN INCREASED RISK OF FRACTURE. IN OSTEOPOROSIS, THE DENSITY AND QUALITY OF BONE ARE REDUCED. THE

More information

The effect of water based exercises on fall risk factors: a mini-review. Dr Esther Vance, Professor Stephen Lord

The effect of water based exercises on fall risk factors: a mini-review. Dr Esther Vance, Professor Stephen Lord The effect of water based exercises on fall risk factors: a mini-review Dr Esther Vance, Professor Stephen Lord Falls and Balance Research Group, NeuRA. There is considerable evidence from systematic reviews

More information

A response by Servier to the Statement of Reasons provided by NICE

A response by Servier to the Statement of Reasons provided by NICE A response by Servier to the Statement of Reasons provided by NICE Servier gratefully acknowledges the Statement of Reasons document from NICE, and is pleased to provide information to assist NICE in its

More information

The Bone Wellness Centre - Specialists in Dexa Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1

The Bone Wellness Centre - Specialists in Dexa Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1 Birth Date: 24.7 years Height / Weight: 8.0 cm 79.0 kg Sex / Ethnic: Male Patient ID: Total Body Tissue Quantitation Composition Reference: Total Tissue 40% 30% 20% 0% 20 30 40 50 60 70 80 90 00 Centile

More information

Osteoporosis International. Original Article. Bone Mineral Density and Vertebral Fractures in Men

Osteoporosis International. Original Article. Bone Mineral Density and Vertebral Fractures in Men Osteoporos Int (1999) 10:265 270 ß 1999 International Osteoporosis Foundation and National Osteoporosis Foundation Osteoporosis International Original Article Bone Mineral Density and Vertebral Fractures

More information

JMSCR Vol 04 Issue 12 Page December 2016

JMSCR Vol 04 Issue 12 Page December 2016 www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v4i12.27 The Prevalence of Osteoporosis and Osteopenia

More information

Bone Density Measurement in Women

Bone Density Measurement in Women Bone Density Measurement in Women Revised 2005 Scope This guideline defines the medical necessity of bone mineral density (BMD) measurement using dualenergy x-ray absorptiometry (DXA or DEXA), and applies

More information

Assessment of the risk of osteoporotic fractures in Prof. J.J. Body, MD, PhD CHU Brugmann Univ. Libre de Bruxelles

Assessment of the risk of osteoporotic fractures in Prof. J.J. Body, MD, PhD CHU Brugmann Univ. Libre de Bruxelles Assessment of the risk of osteoporotic fractures in 2008 Prof. J.J. Body, MD, PhD CHU Brugmann Univ. Libre de Bruxelles Estimated lifetime fracture risk in 50-year-old white women and men Melton et al.;

More information

DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi

DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi DXA When to order? How to interpret? Dr Nikhil Tandon Department of Endocrinology and Metabolism All India Institute of Medical Sciences New Delhi Clinical Utility of Bone Densitometry Diagnosis (DXA)

More information

Update on Falls Prevention Research

Update on Falls Prevention Research Update on Falls Prevention Research Jasmine Menant NSW Falls Prevention Network Rural Forum 8 th March 2018 Acknowledgments: Prof Stephen Lord Recent falls risk factor studies Brain activation in older

More information

BAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008

BAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008 BAD TO THE BONE Peter Jones, Rheumatologist QE Health, Rotorua GP CME Conference Rotorua, June 2008 Agenda Osteoporosis in Men Vitamin D and Calcium Long-term treatment with Bisphosphonates Pathophysiology

More information

Fall Prevention and hip protectors

Fall Prevention and hip protectors Presenter Disclosure Information Edgar Pierluissi Division of Geriatrics Edgar Pierluissi, MD Medical Director, Acute Care for Elders Unit, San Francisco General Hospital and Trauma Center Fall Prevention

More information

Using the FRAX Tool. Osteoporosis Definition

Using the FRAX Tool. Osteoporosis Definition How long will your bones remain standing? Using the FRAX Tool Gary Salzman M.D. Director Banner Good Samaritan/ Hayden VAMC Internal Medicine Geriatric Fellowship Program Phoenix, Arizona Using the FRAX

More information

Systematic Review & Course outline. Lecture (20%) Class discussion & tutorial (30%)

Systematic Review & Course outline. Lecture (20%) Class discussion & tutorial (30%) Systematic Review & Meta-analysisanalysis Ammarin Thakkinstian, Ph.D. Section for Clinical Epidemiology and Biostatistics Faculty of Medicine, Ramathibodi Hospital Tel: 02-201-1269, 02-201-1762 Fax: 02-2011284

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle   holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/22306 holds various files of this Leiden University dissertation. Author: Vochteloo, Anne Jochem Hendrik Title: Determinants of outcome in hip fracture

More information

Submission to the National Institute for Clinical Excellence on

Submission to the National Institute for Clinical Excellence on Submission to the National Institute for Clinical Excellence on Strontium ranelate for the prevention of osteoporotic fractures in postmenopausal women with osteoporosis by The Society for Endocrinology

More information

An audit of osteoporotic patients in an Australian general practice

An audit of osteoporotic patients in an Australian general practice professional Darren Parker An audit of osteoporotic patients in an Australian general practice Background Osteoporosis is a major contributor to morbidity and mortality in Australia, and is predicted to

More information

OSTEOPOROSIS: PREVENTION AND MANAGEMENT

OSTEOPOROSIS: PREVENTION AND MANAGEMENT OSTEOPOROSIS: OVERVIEW OSTEOPOROSIS: PREVENTION AND MANAGEMENT Judith Walsh, MD, MPH Departments of Medicine and Epidemiology and Biostatistics UCSF Definitions Key Risk factors Screening and Monitoring

More information

Bone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008

Bone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008 Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,

More information

CONTRACTING ORGANIZATION: West Virginia University Morgantown, West Virginia

CONTRACTING ORGANIZATION: West Virginia University Morgantown, West Virginia AD AWARD NUMBER: DAMD17-98-1-8513 TITLE: Exercise and Bone Density: Meta-Analysis PRINCIPAL INVESTIGATOR: George A. Kelley, M.D. CONTRACTING ORGANIZATION: West Virginia University Morgantown, West Virginia

More information

1

1 www.osteoporosis.ca 1 2 Overview of the Presentation Osteoporosis: An Overview Bone Basics Diagnosis of Osteoporosis Drug Therapies Risk Reduction Living with Osteoporosis 3 What is Osteoporosis? Osteoporosis:

More information

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist Use of DXA / Bone Density in the Care of Your Patients Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist Important Websites Resources for Clinicians and Patients www.nof.org www.iofbonehealth.org

More information

Management of postmenopausal osteoporosis

Management of postmenopausal osteoporosis Management of postmenopausal osteoporosis Yeap SS, Hew FL, Chan SP, on behalf of the Malaysian Osteoporosis Society Committee Working Group for the Clinical Guidance on the Management of Osteoporosis,

More information

Biological theory for the construct of intrinsic capacity to be used in clinical settings Matteo Cesari, MD, PhD

Biological theory for the construct of intrinsic capacity to be used in clinical settings Matteo Cesari, MD, PhD Biological theory for the construct of intrinsic capacity to be used in clinical settings Matteo Cesari, MD, PhD World Health Organization Geneva (Switzerland) December 1, 2016 World Health Organization.

More information

Assessing Muscle Function and Balance Problems at Home, in the Clinic, and in Research 25 th IOA Colloquium on Aging September 17, 2013

Assessing Muscle Function and Balance Problems at Home, in the Clinic, and in Research 25 th IOA Colloquium on Aging September 17, 2013 Assessing Muscle Function and Balance Problems at Home, in the Clinic, and in Research 25 th IOA Colloquium on Aging September 17, 2013 Bjoern Buehring, M.D. University of Wisconsin School of Medicine

More information

NIH Public Access Author Manuscript Endocr Pract. Author manuscript; available in PMC 2014 May 11.

NIH Public Access Author Manuscript Endocr Pract. Author manuscript; available in PMC 2014 May 11. NIH Public Access Author Manuscript Published in final edited form as: Endocr Pract. 2013 ; 19(5): 780 784. doi:10.4158/ep12416.or. FRAX Prediction Without BMD for Assessment of Osteoporotic Fracture Risk

More information

AACE/ACE Osteoporosis Treatment Decision Tool

AACE/ACE Osteoporosis Treatment Decision Tool AACE/ACE Osteoporosis Treatment Decision Tool What is Osteoporosis? OSTEOPOROSIS is defined as reduced bone strength leading to an increased risk of fracture. Osteoporosis, or porous bones, occurs when

More information

Maturitas 63 (2009) Contents lists available at ScienceDirect. Maturitas. journal homepage:

Maturitas 63 (2009) Contents lists available at ScienceDirect. Maturitas. journal homepage: Maturitas 63 (2009) 34 38 Contents lists available at ScienceDirect Maturitas journal homepage: www.elsevier.com/locate/maturitas Review The role of physical activity in the prevention of osteoporosis

More information

A prospective evaluation of bone mineral density measurement in females who have fallen

A prospective evaluation of bone mineral density measurement in females who have fallen Age and Ageing 2003; 32: 497 502 Age and Ageing Vol. 32 No. 5 British Geriatrics Society 2003; all rights reserved A prospective evaluation of bone mineral density measurement in females who have fallen

More information

Study of secondary causes of male osteoporosis

Study of secondary causes of male osteoporosis Study of secondary causes of male osteoporosis Suárez, S.M., Giunta J., Meneses G., Costanzo P.R., Knoblovits P. Department of Endocrinology, Metabolism and Nuclear Medicine of Hospital Italiano of Buenos

More information

Updates in Osteoporosis. I have no conflicts of interest. What Would You Do? Mrs. C. What s New in Osteoporosis. Page 1

Updates in Osteoporosis. I have no conflicts of interest. What Would You Do? Mrs. C. What s New in Osteoporosis. Page 1 Updates in Osteoporosis Jeffrey A. Tice, MD Associate Professor of Medicine Division of General Internal Medicine, University of California, San Francisco I have no conflicts of interest What s New in

More information

Practical Use of Decision Aids in Primary Care. Michael Soung, MD, FACP Virginia Mason Medical Center General Internal Medicine

Practical Use of Decision Aids in Primary Care. Michael Soung, MD, FACP Virginia Mason Medical Center General Internal Medicine Practical Use of Decision Aids in Primary Care Michael Soung, MD, FACP Virginia Mason Medical Center General Internal Medicine Question #1 40 yo man with total cholesterol 170, HDL 50, LDL 90. African

More information

Available online at ScienceDirect. Osteoporosis and Sarcopenia 1 (2015) 109e114. Original article

Available online at  ScienceDirect. Osteoporosis and Sarcopenia 1 (2015) 109e114. Original article HOSTED BY Available online at www.sciencedirect.com ScienceDirect Osteoporosis and Sarcopenia 1 (2015) 109e114 Original article Localized femoral BMD T-scores according to the fracture site of hip and

More information

Technical Report FORCE ATTENUATION CHARACTERISTICS OF DIFFERENT FORCE ABSORBING MATERIALS USED IN A HIP PROTECTOR FOR THE ELDERLY

Technical Report FORCE ATTENUATION CHARACTERISTICS OF DIFFERENT FORCE ABSORBING MATERIALS USED IN A HIP PROTECTOR FOR THE ELDERLY Technical Report FORCE ATTENUATION CHARACTERISTICS OF DIFFERENT FORCE ABSORBING MATERIALS USED IN A HIP PROTECTOR FOR THE ELDERLY December, 2005 by John W. Chow, Ph.D. Associate Professor Mark D. Tillman,

More information

Correlation between Thyroid Function and Bone Mineral Density in Elderly People

Correlation between Thyroid Function and Bone Mineral Density in Elderly People IBBJ Spring 2016, Vol 2, No 2 Original Article Correlation between Thyroid Function and Bone Mineral Density in Elderly People Ali Mirzapour 1, Fatemeh Shahnavazi 2, Ahmad Karkhah 3, Seyed Reza Hosseini

More information

Low Intensity Training for Frail Elderly Women: Long-term Effects on Motor Function and Mobility

Low Intensity Training for Frail Elderly Women: Long-term Effects on Motor Function and Mobility Original Article Low Intensity Training for Frail Elderly Women: Long-term Effects on Motor Function and Mobility J. Phys. Ther. Sci. 17: 43 49, 2005 TOME IKEZOE 1), AKIMITSU TSUTOU 2), YASUYOSHI ASAKAWA

More information

PFIZER INC. What is the difference in incidence of fracture in women who ever or never used DMPA for contraception?

PFIZER INC. What is the difference in incidence of fracture in women who ever or never used DMPA for contraception? PFIZER INC. These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert. For publications based on this study, see associated bibliography.

More information

Evaluation of Bone Mineral Status in Adolescent Idiopathic Scoliosis

Evaluation of Bone Mineral Status in Adolescent Idiopathic Scoliosis Original Article Clinics in Orthopedic Surgery 2014;6:180-184 http://dx.doi.org/10.4055/cios.2014.6.2.180 Evaluation of Bone Mineral Status in Adolescent Idiopathic Scoliosis Babak Pourabbas Tahvildari,

More information